What is the Fiscal Year for Decoy Therapeutics?
Date: November 13, 2026
Decoy Therapeutics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
CAMBRIDGE, Massachusetts
Industry
Biotechnology Research
Stock Symbol
DCOY
Website
https://salariuspharma.comDescription
At Decoy, we are pioneering a new category of antiviral medicine. Designable Multi-Antivirals (D-MAVs) are engineered to target shared viral mechanisms, enabling a single, adaptable drug to work across multiple viruses. Not one drug for one virus. One platform for many. Built on our proprietary IMP³ACT platform, which integrates rapid peptide synthesis with AI-enabled design, D-MAVs are designed to move faster into the clinic, learn across programs, and reach the people who need them. Viral disease doesn't just make you sick. It disrupts everything around you. We're building with that reality in mind. [decoytx.com]
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Decoy Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.